Pulmonary Embolism International THrOmbolysis Study-3 (PEITHO-3)
A Reduced Dose of Thrombolytic Treatment for Patients With Intermediate High-risk Acute Pulmonary Embolism: a Randomized Controled Trial
Sponsor: Assistance Publique - Hôpitaux de Paris
A PHASE3 clinical study on Pulmonary Embolism, this trial is actively recruiting participants. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 12 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE3
-
Jun 2025 — Sep 2025 [monthly]
Recruiting PHASE3
-
Sep 2024 — Jun 2025 [monthly]
Recruiting PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE3
▶ Show 7 earlier versions
-
Nov 2023 — Jul 2024 [monthly]
Recruiting PHASE3
-
Jul 2023 — Nov 2023 [monthly]
Recruiting PHASE3
-
Jun 2022 — Jul 2023 [monthly]
Recruiting PHASE3
-
Dec 2021 — Jun 2022 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Oct 2021 — Dec 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
- Boehringer Ingelheim
- Canadian Institutes of Health Research (CIHR)
- Instituto de Salud Carlos III
- International Network of VENous Thromboembolism Clinical Research Networks
- Johannes Gutenberg University Mainz
- Life Sciences Research Partners (D Collen Research Foundation)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Almada, Portugal , Ancona, Italy , Angers, France , Bad Krozingen, Germany , Badalona, Spain , Baia Mare, Romania , Barcelona, Spain , Belgrade, Serbia , Berlin, Germany , Besançon, France and 76 more locations